Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2026)

Guardant Health (GH) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $9.4 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 7.76% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (down 7.08% YoY) and the FY2025 annual result came in at $39.7 million, down 6.25% from the prior year.
• Depreciation & Amortization (CF) fell to $9.4 million in Q1 2026 per GH's latest filing, from $10.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $11.0 million in Q3 2023, with the low at $7.2 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $10.0 million, with a median of $10.2 million recorded in 2025.
• Year-over-year, Depreciation & Amortization (CF) surged 76.89% in 2022 and slipped 11.23% in 2025.
• Guardant Health's Depreciation & Amortization (CF) stood at $10.2 million in 2022, then increased by 6.87% to $10.9 million in 2023, then declined by 3.81% to $10.5 million in 2024, then dropped by 3.86% to $10.0 million in 2025, then declined by 6.05% to $9.4 million in 2026.
• Business Quant data shows GH's Depreciation & Amortization (CF) at $9.4 million in Q1 2026, $10.0 million in Q4 2025, and $9.4 million in Q3 2025.